Literature DB >> 25502213

Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation.

Cecilia Analia Panek1, Maria Victoria Ramos1, Maria Pilar Mejias1, Maria Jimena Abrey-Recalde1, Romina Jimena Fernandez-Brando1, Maria Soledad Gori2, Gabriela Verónica Salamone2, Marina Sandra Palermo1.   

Abstract

Circulating monocytes (Mos) may continuously repopulate macrophage (MAC) or dendritic cell (DC) populations to maintain homeostasis. MACs and DCs are specialized cells that play different and complementary immunological functions. Accordingly, they present distinct migratory properties. Specifically, whereas MACs largely remain in tissues, DCs are capable of migrating from peripheral tissues to lymphoid organs. The aim of this work was to analyze the expression of the fractalkine receptor (CX3CR1) during the monocytic differentiation process. Freshly isolated Mos express high levels of both CX3CR1 mRNA and protein. During the Mo differentiation process, CX3CR1 is downregulated in both DCs and MACs. However, MACs showed significantly higher CX3CR1 expression levels than did DC. We also observed an antagonistic CX3CR1 regulation by interferon (IFN)-γ and interleukin (IL)-4 during MAC activation through the classical and alternative MAC pathways, respectively. IFN-γ inhibited the loss of CX3CR1, but IL-4 induced it. Additionally, we demonstrated an association between CX3CR1 expression and apoptosis prevention by soluble fractalkine (sCX3CL1) in Mos, DCs and MACs. This is the first report demonstrating sequential and differential CX3CR1 modulation during Mo differentiation. Most importantly, we demonstrated a functional link between CX3CR1 expression and cell survival in the presence of sCX3CL1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502213      PMCID: PMC4716621          DOI: 10.1038/cmi.2014.116

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  70 in total

1.  Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.

Authors:  D Rojas-Canales; R Krishnan; C F Jessup; P T Coates
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Authors:  Lélia Delamarre; Margit Pack; Henry Chang; Ira Mellman; E Sergio Trombetta
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

Review 3.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

4.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

Authors:  M Amine Bouhlel; Bruno Derudas; Elena Rigamonti; Rébecca Dièvart; John Brozek; Stéphan Haulon; Christophe Zawadzki; Brigitte Jude; Gérard Torpier; Nikolaus Marx; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

5.  IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells.

Authors:  Justin S Ahn; Babita Agrawal
Journal:  Int Immunol       Date:  2005-09-02       Impact factor: 4.823

6.  Fractalkine induces chemotaxis and actin polymerization in human dendritic cells.

Authors:  S Dichmann; Y Herouy; D Purlis; H Rheinen; P Gebicke-Härter; J Norgauer
Journal:  Inflamm Res       Date:  2001-11       Impact factor: 4.575

7.  Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.

Authors:  Ryusuke Yano; Masahiro Yamamura; Katsue Sunahori; Kouji Takasugi; Jiro Yamana; Masanori Kawashima; Hirofumi Makino
Journal:  Acta Med Okayama       Date:  2007-04       Impact factor: 0.892

Review 8.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

9.  Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes.

Authors:  María V Ramos; Gabriela C Fernández; Romina J Fernández Brando; Cecilia A Panek; Leticia V Bentancor; Verónica I Landoni; Martín A Isturiz; Marina S Palermo
Journal:  Immunology       Date:  2009-09-09       Impact factor: 7.397

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  22 in total

1.  Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen.

Authors:  Kohei Fujita; Svetoslav Chakarov; Tetsuro Kobayashi; Keiko Sakamoto; Benjamin Voisin; Kaibo Duan; Taneaki Nakagawa; Keisuke Horiuchi; Masayuki Amagai; Florent Ginhoux; Keisuke Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

2.  Regional Distribution of CNS Antigens Differentially Determines T-Cell Mediated Neuroinflammation in a CX3CR1-Dependent Manner.

Authors:  Aditya Rayasam; Julie A Kijak; McKenna Dallmann; Martin Hsu; Nicole Zindl; Anders Lindstedt; Leah Steinmetz; Jeffrey S Harding; Melissa G Harris; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

Review 3.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

4.  The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

Authors:  Amanda L Collar; Muthulekha Swamydas; Morgan O'Hayre; Md Sanaullah Sajib; Kevin W Hoffman; Satya P Singh; Ahmad Mourad; Melissa D Johnson; Elise Mn Ferre; Joshua M Farber; Jean K Lim; Constantinos M Mikelis; J Silvio Gutkind; Michail S Lionakis
Journal:  JCI Insight       Date:  2018-02-08

5.  Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth.

Authors:  Abhineet M Sharma; Robert Birkett; Erika T Lin; Linda M Ernst; William A Grobman; Suchitra Swaminathan; Hiam Abdala-Valencia; Alexander V Misharin; Elizabeth T Bartom; Karen K Mestan
Journal:  JCI Insight       Date:  2022-06-08

6.  Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.

Authors:  Maria A Clavijo-Salomon; Rosalba Salcedo; Soumen Roy; Rodrigo X das Neves; Amiran Dzutsev; Helioswilton Sales-Campos; Karen Steponavicius-Cruz Borbely; Lucia Silla; Jordan S Orange; Emily M Mace; José A M Barbuto; Giorgio Trinchieri
Journal:  Blood Adv       Date:  2020-08-25

7.  Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension.

Authors:  Stephen Y Chan; Partha Dutta; Jonathan Florentin; Jingsi Zhao; Yi-Yin Tai; Sathish Babu Vasamsetti; Scott P O'Neil; Rahul Kumar; Anagha Arunkumar; Annie Watson; John Sembrat; Grant C Bullock; Linda Sanders; Biruk Kassa; Mauricio Rojas; Brian B Graham
Journal:  Cell Mol Immunol       Date:  2021-01-08       Impact factor: 11.530

Review 8.  Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS.

Authors:  Luciana Frick; Christopher Pittenger
Journal:  J Immunol Res       Date:  2016-12-07       Impact factor: 4.818

9.  Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.

Authors:  Ida Unhammer Njerve; Rune Byrkjeland; Harald Arnesen; Sissel Åkra; Svein Solheim; Ingebjørg Seljeflot
Journal:  Diabetes Metab Syndr Obes       Date:  2016-03-14       Impact factor: 3.168

Review 10.  The Phagocytic Code Regulating Phagocytosis of Mammalian Cells.

Authors:  Tom O J Cockram; Jacob M Dundee; Alma S Popescu; Guy C Brown
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.